Literature DB >> 57093

Incompatibility between C3b and B of guinea-pig and man and its influence on the titration of the alternative pathway factors D and B in these two species.

V Brade, L Dieminger, G Schmidt, W Vogt.   

Abstract

The incubation of the proteins C3b, B, D and C3 induces enzymatic activation of B and of C3. This system of purified components was applied to the titration of the guinea-pig and human factors D and B in various homologous and heterologous reaction mixtures. On the basis of functional as well as of immunological tests, the D enzymes of both species were found to be related proteins. First, titrations of factor B revealed that both D enzymes activate homologous and heterologous B with comparable efficiency. Secondly, a rabbit anti-D antiserum raised against guinea-pig D was found to form a precipitation line of partial identity with guinea-pig and human D. In contrast to the compatibility between heterologous D and B, heterologous combinations of C3b and B were found to be incompatible. This incompatibility was indicated by low titres of D in the presence of heterologous C3b and B; in contrast, in the presence of homologous C3b and B, the titres of D were up to one hundred-fold higher. The reason for this effect was found to reside in inefficient complex formation between heterologous C3b and B. Therefore titrations of D and B should be only performed in the presence of homologous C3b and B.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57093      PMCID: PMC1444978     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.

Authors:  W Vogt; G Schmidt; L Dieminger; R Lynen
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

2.  Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.

Authors:  V Brade; A Nicholson; D Bitter-Suermann; U Hadding
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

3.  The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.

Authors:  V Brade; A Nicholson; G D Lee; M M Mayer
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

4.  The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.

Authors:  V Brade; G D Lee; A Nicholson; H S Shin; M M Mayer
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

5.  Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement.

Authors:  W Vogt; L Dieminger; R Lynen; G Schmidt
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-02

6.  Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B.

Authors:  R Lynen; V Brade; A Wolf; W Vogt
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973-01

7.  Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).

Authors:  V Brade; C T Cook; H S Shin; M M Mayer
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

8.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

9.  Properdin factor D: characterization of its active site and isolation of the precursor form.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

10.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  3 in total

1.  Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.

Authors:  C Bentley; W Fries; V Brade
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  Isolation and characterization of the third component of rat complement.

Authors:  M R Daha; M Stuffers-Heiman; A Kijlstra; L A van Es
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

3.  The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.

Authors:  M S Edwards; A Nicholson-Weller; C J Baker; D L Kasper
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.